3rd Quarter - Report
AKIN GUMP STRAUSS HAUER & FELD for KYVERNA THERAPEUTICS, INC.
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to developing cell and gene therapies for patients, including Stiff Person Syndrome, rare disease, and multiple sclerosis; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA ABRAM | — |
| KANDIS MCCLURE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.